Skip to content
  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved

Beyond Vaccines: The Expanding RNA-Lipid Nanoparticle Landscape

by Xingyu (Jasmine) Hu | December 22nd, 2025

Introduction Few scientific breakthroughs have reshaped modern medicine as dramatically as lipid nanoparticles (LNPs). Once a niche area in nucleic acid delivery research, these tiny lipid assemblies became the cornerstone of the world’s COVID-19 response. When Pfizer/BioNTech and Moderna deployed their mRNA–LNP vaccines in record time, they not only helped curb a global pandemic—they unveiled […]

Read More

‘Processing’ An Old and Evolving Challenge for Plant-Based Innovation

by Charlie Mineo | December 27th, 2025

In the U.S., the phrase ‘vegan proteins’ once conjured images of simple foods like nuts, beans, or tofu. But over the past 10 years, an array of plant-based alternatives have painted a different picture—one filled with imitation milk, eggs, and meat that closely mimic their animal-derived counterparts. These products have been successful thanks to food-tech […]

Read More

Harvesting our gut communities to treat disease

by Lindsey Fontenot | December 12, 2022

A look at fecal microbiota transplants in universities and biotech companies Trillions of bacteria, along with some fungi, viruses, and archaea, make up our gut microbiome. These bacteria greatly outnumber our own cells and play a crucial role in our bodies. Researchers are exploring gut microbiome interventions to improve human health. In the last several […]

Read More

Promoting innovation in academia: from universities to startups and beyond

by Sarah Van Houten | August 25, 2022

With both industry and the academic community working together, innovative ideas generated at universities could potentially lead to more successful startups and a better workforce.

Read More

The fight against the silent pandemic: a synergistic effort for combating antimicrobial resistance

by Kristel C. Tjandra, PhD | May 23, 2022

The world is running out of weapons to fight against the threat of superbugs. A collective effort from healthcare, government, and industry is needed.  

Read More

Lessons from microbial growing pains

by Andrew Saintsing | December 22, 2021

While our society has grown accustomed to microbe-produced medicines like penicillin and insulin, biotechnology startups today, especially those in the San Francisco Bay Area, are increasingly looking to use these microscopic chemists in industries beyond pharmaceuticals. 

Read More

Taking the high road: turning to drugs to treat addiction

by Alyssa DiLeo | December 22, 2021

Researchers are once again pursuing psychedelic drugs as potential treatments for neuropsychiatric disorders, such as substance use disorder. This comes at a crucial time when drug use and overdose deaths have increased during the ongoing COVID-19 pandemic.

Read More

Could collaborative biotech teams close the gap in cancer research?

by Jessica Maldonado-Mendoza, PhD | December 14, 2021

By 2040, cancer cases are expected to significantly rise in Latin America and Asia. But a lack of technology, trained personnel, funding, and diminished participation interfere with scientists’ fight against cancer in these regions.

Read More

Toward an equitable and inclusive science communication landscape

by Kelly Montgomery | June 16th, 2021

As scientists push to reach broader audiences and better communicate the science behind their leading technologies, there has been an uptick in the market supporting the emerging business of scientific communication. Organizations are coming to realize that effective communication between companies and their stakeholders, including investors, policymakers, and the general public is critical to their […]

Read More

Science trainees, have you considered a career in technology transfer?

by Nnamdi Nelson, PhD | May 29th, 2021

When I was younger, I regularly watched science documentaries and was inspired by how scientific breakthroughs could improve lives. Over the years, my admiration for scientists and the scientific process grew and led me to pursue a graduate degree in neuroscience. As I continue on my educational journey and training, I’ve realized that it takes […]

Read More

Next »

To learn more about how BCBA can
help your business or organization,
please contact us at info@biotechconnectionbay.org

2026 © Biotech Connection - Bay Area, Inc., All Rights Reserved

Biotech Websites Design by Thomas Digital

  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved